Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

French industry bemoans loss of presence on regulatory bodies

This article was originally published in Scrip

Executive Summary

France's drug regulatory agency, Afssaps, has published details of the new membership of its various bodies and committees, including those responsible for drug approvals and pharmacovigilance. The move is noteworthy because the pharmaceutical industry no longer has representation on any of these committees - or indeed on the agency's board.